Clinical Rheumatology

, 5:181 | Cite as

Lung function abnormalities in different connective tissue diseases

  • C. Vitali
  • G. Viegi
  • S. Tassoni
  • A. Tavoni
  • P. Paoletti
  • E. Bibolotti
  • C. Ferri
  • S. Bombardieri


Lung volumes, forced expiratory flow-volume curves, diffusing capacity indexes, and arterial blood gases were measured in 72 non-smoking patients with various connective tissue diseases (13 with rheumatoid arthritis, 17 with systemic lupus erythematosus, 25 with progressive systemic sclerosis, 10 with primary Sjögren's syndrome, 4 with polymyositis, and 3 with mixed connective tissue disease). Small airways disease and a diffusion capacity impairment were the most frequent and marked functional abnormalities in the whole group, and were often present in asymptomatic patients. Different lung function defects seemed to be present in each disease group. In fact, large airway obstruction was prevalent in progressive systemic sclerosis, diffusion capacity impairment in systemic lupus erythematosus, and small airways disease in rheumatoid arthritis. In contrast, primary Sjögren's syndrome appeared to be the connective tissue disease in which lung function abnormalities were less frequent and less pronounced.

Key words

Lung Volume Measurement Airway Obstruction Pulmonary Diffusing Capacity Connective Tissue Diseases 


  1. 1.
    Hunninghake, G.W., Fauci, A.S. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979, 119, 471–503.PubMedGoogle Scholar
  2. 2.
    Case Record of the Massachusetts General Hospital: Case 28-1975. N Engl J Med 1975, 293, 136–144.Google Scholar
  3. 3.
    Vitali, C., Tavoni, A., Simi, U., Viegi, G., Bombardieri, S. Plasma cell granuloma in a patient with Sjögren's syndrome. J Rheumatol (in press).Google Scholar
  4. 4.
    Christie, G.S. Pulmonary lesions in rheumatoid arthritis. Aust Ann Med 1954, 3, 49–55.PubMedGoogle Scholar
  5. 5.
    Frank, S.T., Weg, J.G., Harkleroad, L.E., Fitch, R.F. Pulmonary disfunction in rheumatoid disease. Chest 1973, 63, 27–34.PubMedCrossRefGoogle Scholar
  6. 6.
    Eisemberg, H., Dubois, E.L., Sherwin, R.P., Balchum, O.J. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973, 79, 37–45.PubMedGoogle Scholar
  7. 7.
    Adhikari, P.K., Bianchi, F.A., Boushy, S.F., Sakamoro, A., Lewis, B.M. Pulmonary function in scleroderma. Its relation to changes in the chest roentgenogram and in the skin in the thorax. Am Rev Respir Dis 1962, 86, 823–831.PubMedGoogle Scholar
  8. 8.
    Schwarz, M.I., Matthay, R., Sahn, S.A., Stanford, R.E., Marmostein, B.L., Scheinhorm, D.J. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976, 55, 89–104.Google Scholar
  9. 9.
    Segal, I., Fink, G., Machtey, I., Gura, V., Spitzer, S.A. Pulmonary function abnormalities in Sjögren's syndrome and the sicca complex. Thorax 1981, 36, 286–289.PubMedGoogle Scholar
  10. 10.
    Silver, T.M., Farber, S.J., Bole, G.G., Martel, W. Radiological features of mixed connective tissue disease and scleroderma-systemic lupus erythematosus overlap. Radiology, 1976, 120, 269–275.PubMedGoogle Scholar
  11. 11.
    Huang, C.T., Lyons, H.A. Comparison of pulmonary function in patients with systemic lupus erythematosus, scleroderma, and rheumatoid arthritis. Am Rev Respir Dis 1966, 93, 865–875.PubMedGoogle Scholar
  12. 12.
    Garland, L.H., Sisson, M.A., Roentgen findings in «collagen» diseases. Am J Roentgenol. 1954, 71, 581–598.Google Scholar
  13. 13.
    Constantopoulos, S.H., Acriditis, N.K., Dalavanga, Y.A., Moutsopoulos, H.M. Respiratory involvement in autoimmune rheumatic diseases is frequent and easy to detect. Clin Exp Rheumatol 1983, 1, 233–236.PubMedGoogle Scholar
  14. 14.
    Ropes, M.W., Bennet, G.A., Cobb, S., Jacox, R., Jessar, R.A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958, 9, 175–176.PubMedGoogle Scholar
  15. 15.
    Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271–1277.PubMedCrossRefGoogle Scholar
  16. 16.
    Masi, A.T., Radnan, G.P., Medsger, T.A., Altman, R.D., D'Angelo, W.A., Fries, J.F., LeRoy, E.C., Kirsner, A.B., MacKenzie, A.H., McShane, D.J., Myers, A.R., Sharp, G.C. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23, 581–590.PubMedCrossRefGoogle Scholar
  17. 17.
    Ansell, B.M. Dermatomyositis and polymyositis. In: Copeman's textbook of Rheumatic Diseases. Editor: Scott, J.T. Edimburg, Churchill-Livingstone, 1978.Google Scholar
  18. 18.
    Moutsopoulos, H.M. Sjögren's syndrome (sicca syndrome): current issues. Ann Intern Med 1980, 92, 212–226.PubMedGoogle Scholar
  19. 19.
    Sharp, G.C., Irvin, W.S., Tan, E.M., Gould, R.G., Holman, H.R. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52, 148–159.CrossRefPubMedGoogle Scholar
  20. 20.
    Vitali, C., Tavoni, A., Viegi, G., Begliomini E., Agnesi, A., Bombardieri S. Lung involvement in Sjögren's syndrome: a comparison between patients with primary and secondary syndrome. Ann Rheum Dis 1985, 44, 455–461.PubMedCrossRefGoogle Scholar
  21. 21.
    Ogilvie, C.M., Forster, R.E., Blakemore W.S., Morton, J.W., A Standardized breath-holding technique for the clinical measurement of the diffusing capacity of the lung carbon monoxide. J Clin Invest 1957, 36, 1–17.PubMedCrossRefGoogle Scholar
  22. 22.
    Bates, D.V., MacKlem, P.T., Christie, R.V. Respiratory function in disease. Philadelphia, WB Saunders Company, 1971.Google Scholar
  23. 23.
    Goldman, H.I., Becklake, M.R. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuber 1959, 79, 457–467.Google Scholar
  24. 24.
    Morris, J.F., Koski, A., Breese, J.D. Normal values and evaluation of forced end-expiratory flow. Am Rev Respir Dis 1975, 111, 755–762.PubMedGoogle Scholar
  25. 25.
    Knudson, R.J., Slatin, R.C., Lebowitz, M.D., Burrows, B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976, 113, 587–600.PubMedGoogle Scholar
  26. 26.
    Cotes, J.E., Hall, A.M. The transfer factor for the lung: normal values in adult. In: Introduction to the definition of normal values for respiratory function in man. Editors: Arcangeli, P., Cotes, J.E., Cournand, A., et al. Torino, Panminerva Medica, 1970, 327–343.Google Scholar
  27. 27.
    Manca, F., Migliorini, P., Bombardieri, S., Celada, F. An enzymatically active antigen antibody probe to measure circulating immune complexes by competition. Clin Immunol Immunopathol 1980, 16, 131–141.CrossRefPubMedGoogle Scholar
  28. 28.
    Kent, J.F., Fife, E.H. Jr. Precise standardization of reagents for complement fixation. Am J Trop Med Hyg 1963, 12, 103–141.PubMedGoogle Scholar
  29. 29.
    MacKlem, P.T., Thurlbeck, W.M., Frafer, R.G. Chronic obstructive disease of the small airways. Ann Intern Med 1971, 74, 167–177.PubMedGoogle Scholar
  30. 30.
    Crystal, R.G., Gadek, J.E., Ferrans, V.J., Fulmer, J.D., Line, B.R., Hanninghake, G.W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981, 70, 542–568.CrossRefPubMedGoogle Scholar
  31. 31.
    Salomon, A., Appel, B., Dougherthy, E.F., Herschfus, J.A., Segal, M.S. Scleroderma: Pulmonary and skin studies before and after treatment with cortisone. Arch Intern Med 1955, 95, 103–111.Google Scholar
  32. 32.
    Catterall, M., Rowell, N.R. Respiratory function in progressive systemic sclerosis. Thorax 1963, 18, 10–15.PubMedGoogle Scholar
  33. 33.
    Hughes, D.T., Lee, F.I. Lung function in patients with systemic sclerosis. Thorax 1963, 18, 16–20.PubMedCrossRefGoogle Scholar
  34. 34.
    Ritchie, B. Pulmonary function in scleroderma. Thorax 1964, 19, 28.PubMedCrossRefGoogle Scholar
  35. 35.
    Ashba, J.K., Ghanem, M.H. The lungs in systemic sclerosis. Dis Chest 1965, 47, 52–64.PubMedCrossRefGoogle Scholar
  36. 36.
    Guttadauria, M., Ellman, H., Emmanuel, G., Kaplan, D., Diamond, H. Pulmonary function in scleroderma. Arthritis Rheum 1977, 20, 1071–1079.PubMedCrossRefGoogle Scholar
  37. 37.
    Collins, R.L., Turner, R.A., Johnson, A.M., Whiltley, N.O., McLean, R.L. Obstructive pulmonary disease in rheumatoid arthritis. Arthritis Rheum 1976, 19, 623–628.PubMedCrossRefGoogle Scholar
  38. 38.
    Mountz, J.D., Turner, R.A., Collins, R.L., Gallup, K.R. Jr., Semble, E.L. Rheumatoid arthritis and small airways function. Effects of disease activity, smoking, and α1 — antitrypsin deficiency. Arthritis Rheum 1984, 27, 728–736.PubMedCrossRefGoogle Scholar
  39. 39.
    Silberstein, S.L., Barland, P., Grayzel, A.I., Koerner, S.K. Pulmonary disfunction in systemic lupus erythematosus: prevalence, classification, and correlation with other organ involvement. J Rheumatol 1980, 7, 187–195.PubMedGoogle Scholar
  40. 40.
    Yeo, P.P., Sinniah, R. Lupus cor pulmonare with electron microscope and immunofluorescent antibody studies. Ann Rheum Dis 1975, 34, 457–460.PubMedCrossRefGoogle Scholar
  41. 41.
    Bretjens, J.R., O'Connell, D.W., Pawlowski, I.R. Hsu, K.C., Andres, G.A. Experimental immune complex disease of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung diseases. J Exp Med 1974, 140, 105–125.CrossRefPubMedGoogle Scholar
  42. 42.
    Migliorini, P., Riente, L., Manca, F., Celada, F., Bombardieri, S. Coldprecipitable immune complexes in collagen diseases: evidence for the coexistence of multiple types of circulating complexes in human serum. Clin Immunol Immunopathol 1983, 29, 129–140.CrossRefPubMedGoogle Scholar
  43. 43.
    Migliorini, P., et al. Comparison of pathological and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian Committee for the Study of Immune Complexes (WIC). Clin Immunol Immunopathol 1984, 32, 298–315.CrossRefPubMedGoogle Scholar
  44. 44.
    Strimlan, C.V., Rosenow, E.C. 3rd., Divertie, M.B., Harrison, E.G. Jr. Pulmonary manifestations of Sjögren's syndrome. Chest 1976, 70, 354–361.PubMedCrossRefGoogle Scholar
  45. 45.
    Newball, H.H., Brahim, S.A. Chronic obstructive airways disease in patients with Sjögren's syndrome. Am Rev Respir Dis 1977, 115, 295–304.PubMedGoogle Scholar
  46. 46.
    Fairfax, A.J., Haslam, P.L., Pavia, D., Sheahan, N.F., Bateman, J.R.M., Agnew, J.E., Clarke, S.W., Turner-Warwick, M. Pulmonary disorders associated with Sjögren's syndrome. Q J Med 1981, 50, 279–295.PubMedGoogle Scholar
  47. 47.
    Oxholm, P., Bundgaard, A., Birk Madsen, E., Manthorpe, R., Vejilö Rasmussen, F. Pulmonary function in patients with primary Sjögren's syndrome. Rheumatol Int 1982, 2, 179–181.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • C. Vitali
    • 1
  • G. Viegi
    • 3
  • S. Tassoni
    • 1
  • A. Tavoni
    • 1
  • P. Paoletti
    • 2
  • E. Bibolotti
    • 1
  • C. Ferri
    • 1
  • S. Bombardieri
    • 1
  1. 1.Rheumatic Disease UnitPisaItaly
  2. 2.2nd Medical ClinicUniversity of PisaPisaItaly
  3. 3.Pulmonary UnitCNR Clinical Physiology InstitutePisaItaly

Personalised recommendations